-
Vaxart, Inc. is an
American biotechnology company focused on the discovery, development, and
commercialization of oral
recombinant vaccines administered...
-
Vaxart COVID-19
vaccine is a COVID-19
vaccine candidate developed by
Vaxart.
Clinical trial number NCT04563702 for "Safety and
Immunogenicity Trial of...
-
August 2021.
Retrieved 13
November 2014. "
Vaxart Completes Financing to Fund
Expanding Development Portfolio".
Vaxart.
Archived from the
original on 19 January...
-
August 2020
against Vaxart in
Northern California U.S.
District Court for
alleged securities fraud, a
concern related to
Vaxart executives enriching...
- DelNS1-2019-nCoV-RBD-OPT GRAd-COV2
ImmunityBio iNCOVACC INNA-051 NDV-HXP-S
Vaxart COVID-19
vaccine Virus-like
particles ABNCoV2 LYB001 MigVax-101 VBI-2902...
- Pharmaceutical), AstraZeneca-University of Oxford, Pfizer-BioNTech, Moderna, Merck,
Vaxart, and Inovio.
Funding from
BARDA totaled more than $2
billion by the end...
- Randomized, double-blinded, placebo-controlled. July–Dec 2021,
China Vaxart COVID-19
vaccine Vaxart United States Viral vector Phase II (896) Double-Blind, Multi-Center...
- for a
number of
biotechnology companies including Day One Therapeutics,
Vaxart and WinSanTor. He also
served as CEO of Poliwogg. "Greg Simon". The Forum...
